CEP290 / Centrosomal protein of 290 kDa · Western blot design guide

Design a Western Blot for CEP290

Real validated CEP290 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-CEP290 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for CEP290: expected band ~290.4 kDa, hero antibody A01894, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable CEP290 Western blot protocol sheet — expected band ~290.4 kDa, antibody A01894, controls and PMC citations. Open the full CEP290 WB guide →

CEP290 Western Blot Experimental Design Guide

Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~290.4 kDa
Gel 4–12% gradient (standard starting point)
Positive control ⓘ Adrenal gland (IHC candidate; verify WB) +4 more
Negative control ⓘ Soft tissue (IHC candidate; verify WB)
Important caveats
Reasons your observed band may differ from the expected size.
PTM Ubl conjugation
Caveat Modification-state controls
Gene-set association MSigDB C7 membership
Isoform 1 isoform(s)
Section 1

Real Curated CEP290 Western Blot Protocols

The A01894 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysateHCT116 (40ug), SGC7901 (40ug), COS-7 (40ug) (catalog A01894)
Gel %4–12% gradient (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferWet/tank transfer; optimize duration (standard starting point)
Membrane0.45 µm PVDF (standard starting point)
Blocking5% milk or 5% BSA in TBST (standard starting point)
Primary antibodyA01894; use the WB datasheet starting dilution (standard starting point)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodySpecies-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL; bracket exposures to avoid saturation (standard starting point)
Section 2

What Is the Expected CEP290 Western Blot Band Size?

CEP290 is predicted at 290.4 kDa; its listed features do not demonstrate different migration, and no empirical band size is supplied.

What am I looking at on my blot?
Band near 290.4 kDaConsistent with the predicted size of full-length CEP290; confirm its identity
Faint band near 290.4 kDa in whole-cell lysateCEP290 may be poorly recovered from its centrosomal and cytoskeletal locations
No band in a soluble fractionCentrosomal or cytoskeletal CEP290 may remain in the insoluble fraction
Stronger band near 290.4 kDa in a cytoskeletal fractionConsistent with enrichment of localized CEP290; confirm its identity
💡Expected CEP290 appearanceUniProt predicts full-length CEP290 at 290.4 kDa; no empirical band size is supplied, so confirm a band near that size with ordinary band-identity controls.
How each factor affects band size
UniProt predicted massPlaces full-length CEP290 at 290.4 kDa by sequence calculation
290386 Da calculated massCorresponds to approximately 290.4 kDa for full-length CEP290
Full-length sequence predictionProvides a size reference without establishing electrophoretic migration
Single listed isoformProvides no evidence for a second isoform band at a different size
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateCentrosomal and cytoskeletal CEP290 may be poorly recovered in the tested fractionCheck fraction recovery and include a positive control
Band higher than expectedThe supplied features do not establish the causeConfirm identity with CEP290 depletion or a second antibody
Band lower than expectedThe supplied features do not establish a cleavage productCheck sample integrity and confirm identity with a second antibody
Multiple bandsNo distinct isoform masses or processing products are supplied to identify themCheck which bands disappear after CEP290 depletion
Weak or no signalRecovery of localized CEP290 may be lowAssess extraction and loading with a positive control

Sample controls for CEP290 Western blot

🧪HPA-IHC candidate guidance (verify in WB): For positive controls for CEP290 in Western blot, you can use adrenal gland tissue.
Positive control: Adrenal gland (IHC candidate; verify WB)
Negative control: Soft tissue (IHC candidate; verify WB)
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside.
⚠️Feasibility: Soft tissue is HPA not detected, but its Western blot signal should be checked.

HPA tissue expression evidence for CEP290

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
Adrenal gland glandular cells High Protein (IHC) HPA →
Appendix glandular cells High Protein (IHC) HPA →
Breast glandular cells High Protein (IHC) HPA →
Bronchus ciliated cells (cell body) High Protein (IHC) HPA →
Cerebellum cells in granular layer High Protein (IHC) HPA →

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
Soft tissue chondrocytes Not detected Protein (IHC) HPA →
Adipose tissue adipocytes Low Protein (IHC) HPA →
Epididymis glandular cells Low Protein (IHC) HPA →
Skeletal muscle myocytes Low Protein (IHC) HPA →
Bone marrow hematopoietic cells Medium Protein (IHC) HPA →
Section 3

Advanced CEP290 Western Blot Tips

Deeper troubleshooting and optimisation questions for CEP290, answered from its protein features.

Where should the full-length CEP290 band appear?
Band shift · CEP290 is 2,479 amino acids long with a predicted mass of 290.4 kDa. Use that value to identify a candidate full-length band, but assess identity with appropriate controls; no empirical apparent band position is supplied.
Does UniProt support multiple CEP290 isoform bands?
Isoforms · The supplied record lists one isoform and no alternative sequence. It therefore provides no basis for assigning separate bands to annotated isoforms.
Could modification explain a shifted CEP290 band?
PTM · Ubl conjugation appears among the keywords, but the supplied features list no modified residues or modification coordinates. These features cannot establish whether a modification causes a visible shift or explain a difference from 290.4 kDa.
Does this guide establish induction of CEP290?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
What transfer method to use for CEP290 Western blot?
Transfer · CEP290 has a predicted mass of 290.4 kDa. Choose a transfer setup suitable for a protein of that size and check transfer efficiency near 290 kDa. The supplied features do not specify a membrane or transfer settings.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A01894 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should CEP290 band intensity be quantified?
Quantitation · Quantify a consistently identified band near the expected full-length size and normalize it to a suitable loading measure. Because the supplied record gives no empirical band position, verify band identity before comparing intensities.
How should unexpected lower CEP290 bands be interpreted?
Interpretation · Do not assign lower bands to annotated isoforms: the supplied record lists only one isoform. Compare bands with an appropriate specificity control before attributing them to CEP290; the supplied features do not identify their cause.
Boster reagents

CEP290 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot (WB) analysis of CEP290 (F812) polyclonal antibody at 1:500 dilution Lane1:HCT116 whole cell lysate(40ug) Lane2:SGC7901 whole cell lysate(40ug) Lane3:COS-7 whole cell lysate(40ug) Lane4:A549 whole cell lysate(40ug) Lane5:CT26 whole cell lysate(40ug) Lane6:AML-12 whole cell lysate(40ug) Lane7:PC12 whole cell lysate(40ug)
Anti-CEP290 (F812) Antibody
Cat # A01894
Real WB data Western Blot analysis of various cells using CEP290 Polyclonal Antibody
Anti-Centrosomal protein of 290 kDa CEP290 Antibody
Cat # A01894-1
Real WB data Western Blot analysis of various cells using CEP290 Polyclonal Antibody
Anti-Centrosomal protein of 290 kDa CEP290 Antibody
Cat # A30603

Three the supplier anti-CEP290 polyclonal antibodies are listed with WB images. A01894 has a caption naming seven cell lysates, 40 µg per lane, and a 1:500 dilution; the other two captions describe only unspecified cells.

Which to pick: Choose A01894 if you need reported rat reactivity or a WB example with named lysates and conditions. A01894-1 and A30603 list human and mouse reactivity, but their WB captions give no specific samples or conditions.

Source: BosterBio CEP290 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.